A mixed micellar formulation for the transdermal delivery of an Indirubin analog
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo S.H. | - |
dc.contributor.author | Kim E. | - |
dc.contributor.author | Joo Y. | - |
dc.contributor.author | Lee J. | - |
dc.contributor.author | Oh K.T. | - |
dc.contributor.author | Hwang S.-J. | - |
dc.contributor.author | Choi K.-Y. | - |
dc.date.available | 2020-04-03T02:55:56Z | - |
dc.date.issued | 2020-02 | - |
dc.identifier.issn | 1999-4923 | - |
dc.identifier.issn | 1999-4923 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/37904 | - |
dc.description.abstract | Indirubin is an active component of Dang Gui Long Hui Wan, which has been used in traditional Chinese medicine to treat inflammatory diseases as well as for the prevention and treatment of human cancer, such as chronic myeloid leukemia. The therapeutic effects of indirubin analogs have been underestimated due to its poor water solubility and low bioavailability. To improve the solubility and bioavailability of indirubin analogs, we prepared a mixed micellar formulation with Kolliphor® EL and Tween 80 as surfactants, and PEG 400 as a co-surfactant, followed by complexation with (2-hydroxyproply)-β-cyclodextrin at appropriate ratios. Overall, improving the solubility and skin penetration of indirubin analogs can increase clinical efficacy and provide maximum flux through the skin. © 2020 by the authors. Licensee MDPI, Basel, Switzerland. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI AG | - |
dc.title | A mixed micellar formulation for the transdermal delivery of an Indirubin analog | - |
dc.type | Article | - |
dc.identifier.doi | 10.3390/pharmaceutics12020175 | - |
dc.identifier.bibliographicCitation | Pharmaceutics, v.12, no.2 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000519268500103 | - |
dc.identifier.scopusid | 2-s2.0-85079697844 | - |
dc.citation.number | 2 | - |
dc.citation.title | Pharmaceutics | - |
dc.citation.volume | 12 | - |
dc.type.docType | Article | - |
dc.publisher.location | 스위스 | - |
dc.subject.keywordAuthor | Lipophilic drugs | - |
dc.subject.keywordAuthor | Mixed micellar formulation | - |
dc.subject.keywordAuthor | Solvent-free delivery system | - |
dc.subject.keywordAuthor | Transdermal drug delivery | - |
dc.subject.keywordPlus | PENETRATION ENHANCERS | - |
dc.subject.keywordPlus | DRUG | - |
dc.subject.keywordPlus | SYSTEM | - |
dc.subject.keywordPlus | BIOAVAILABILITY | - |
dc.subject.keywordPlus | MICROEMULSION | - |
dc.subject.keywordPlus | STRATEGIES | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.